Looked at this one last night, and got in this morning at 3.1c. At one stage today, the SP had appreciated 515%. It finished 352.6% up ... incredible.
I reviewed the AGM presentation and yesterday's announcement, and was attracted by the following:
$10 billion+ pa target market (pathology suppliers, bead manufacturers, research organisations, point of care).
Product with numerous competitive advantages:
President of Bangs Laboratories, Inc., Mr Chad Owen, said, “I have been in this business for more than 13 years now and regularly encounter interesting new technologies. The Anteo Mix&Go technology is one of the most exciting innovations I have seen in all of that time.”
Product is ready for sale, with no further development work needed.
Engaged in advanced discussions with major market participants across all segments.
Anteo CEO, Dr Geoff Cumming, said: "Before any new process is introduced in the production of new healthcare products rigorous and lengthy testing must be undertaken. Several other major market participants are nearing the end of their internal testing requirements for the application of Mix&GoTM. It is our expectation that more licences will be granted in the near future as additional companies confirm the technical, cost and manufacturing benefits that accrue from our product.”
The announcement further suggests that revenues will start soon:
First revenues from the agreement are expected to be received in the first quarter of 2010.
While no numbers are given in yesterday's announcement, in their recent AGM presentation they indicate potential annuity royalty revenues of $140m-390m (5 year horizon).
These fundamentals appeared quite attractive to me for a company with only a ~$10m market cap (when I bought in).
Obviously, it's a speculative stock though - please do your own research and make decisions based on your own risk tolerance.